Innovent Biologics Inc. (IVBXF)
PNK: IVBXF
· Real-Time Price · USD
7.39
0.31 (4.45%)
At close: May 23, 2025, 2:18 PM
Innovent Biologics Revenue
Innovent Biologics reported an annual revenue of $9.42B, reflecting a 51.82% growth. For the quarter ending December 31, 2024, Innovent Biologics generated $5.47B in revenue.
Revenue (ttm)
$9.42B
Revenue Growth
51.82%
Price / Sales Ratio
5.5
Revenue / Employee
$1.66M
Employees
5,659
Market Cap
12.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|